Evidence map›Paper›PMID 41513687›Full record

ArticleNPJ biofilms and microbiomes2026

Vaginal bacteria-derived extracellular vesicles diffuse through human cervicovaginal mucus to enable microbe-host signaling.

Darby Steinman, Alyssa P Petersen, Yasmi Chibber, Caleb Crawford, Pranshu Tyagi, Hannah C Zierden

Abstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Optimizing genetic engineering approaches for protein loading into bacterial extracellular vesicles for vaginal drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Darby SteinmanFischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
Alyssa P PetersenDepartment of Chemical & Biomolecular Engineering, University of Maryland, College Park, MD, USA.
Yasmi ChibberDepartment of Chemical & Biomolecular Engineering, University of Maryland, College Park, MD, USA.
Caleb CrawfordDepartment of Chemical & Biomolecular Engineering, University of Maryland, College Park, MD, USA.
Pranshu TyagiDepartment of Chemical & Biomolecular Engineering, University of Maryland, College Park, MD, USA.
Hannah C ZierdenFischell Department of Bioengineering, University of Maryland, College Park, MD, USA. hzierden@umd.edu.

Funding

Johns Hopkins Institute for Clinical and Translational ResearchUM1TR004926 · NCATS · JOHNS HOPKINS UNIVERSITY · PI STEPHEN N. DAVIS, Daniel Ernest Ford · 2024 to 2026
$28.5M
Zeiss LSM 880 Airyscan Fast Laser Scanning ConfocalS10OD025223 · OD · UNIV OF MARYLAND, COLLEGE PARK · PI BEAVEN, AMY · 2019 to 2019
$557k
NCATS NIH HHS UM1 TR004926NCATS NIH HHS UM1TR004926NIH HHS S10 OD025223
6 · The paper itself

Abstract

The composition of the vaginal microenvironment has significant implications for gynecologic and obstetric outcomes. Where a Lactobacillus-dominated microenvironment is considered optimal, a polymicrobial environment is associated with increased risk for female reproductive diseases. Recent work examined bacteria-derived extracellular vesicles (bEVs) as an important mode of microbe-host communication that may influence reproductive outcomes. However, in order to communicate with female reproductive tissues, bEVs must penetrate the protective cervicovaginal mucus barrier. We demonstrate increased diffusion of bEVs compared to whole bacteria. Additionally, we evaluate the uptake of bEVs by, and the resulting effects on, human vaginal epithelial, endometrial, and placental cells, highlighting potential mechanisms of action by which vaginal dysbiosis contributes to gynecologic and obstetric diseases. Taken together, our work demonstrates the ability of bEVs to mediate female reproductive outcomes and highlights their potential as therapeutic modalities for treating dysbiosis and dysbiosis-associated diseases in the female reproductive tract.

Indexed as

BacteriaCervix MucusExtracellular VesiclesHost Microbial InteractionsVaginaCervix UteriDysbiosisEndometriumEpithelial CellsFemaleHumansSignal Transduction

Identifiers

PMID41513687
PMCPMC12789437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.